Free Trial
NYSEARCA:BOUT

Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News

$41.35 +0.81 (+2.00%)
As of 01/21/2025 04:10 PM Eastern

About Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Key Stats

Today's Range
$41.13
$41.35
50-Day Range
$38.61
$42.41
52-Week Range
$32.53
$42.41
Volume
1,791 shs
Average Volume
3,449 shs
Market Capitalization
$16.54 million
Assets Under Management
$13.92 million
Dividend Yield
0.97%
Net Expense Ratio
0.85%
Aggregate Rating
Moderate Buy

ETF Overview

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.

Innovator IBD Breakout Opportunities ETF Expenses

TypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.80%0.47%0.55%0.51%0.52%
Other Expenses0.05%0.39%0.49%0.57%0.54%
Total Expense0.85%0.62%0.71%0.73%0.71%
Fee Waiver0.00%-0.42%-0.51%-0.66%-0.56%
Net Expense0.85%0.53%0.61%0.58%0.59%
Receive BOUT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter.

BOUT ETF News Headlines

Stunning Trump Manhattan Project Now Underway
Just as I predicted, President Trump announced his #1 move during his first 100 days... His allies are calling it Trump’s Manhattan Project.
See More Headlines

BOUT ETF - Frequently Asked Questions

Innovator IBD Breakout Opportunities ETF's stock was trading at $39.07 on January 1st, 2025. Since then, BOUT shares have increased by 5.8% and is now trading at $41.35.
View the best growth stocks for 2025 here
.

Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD Breakout Opportunities ETF investors own include NVIDIA (NVDA), ARK Innovation ETF (ARKK), CRISPR Therapeutics (CRSP), Carvana (CVNA), Fastly (FSLY), Luckin Coffee (LKNCY) and Cloudflare (NET).

Fund Details

Issuer
Innovator Capital Management
Fund Name
Innovator IBD Breakout Opportunities ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:BOUT
Inception Date
9/13/2018
Fund Manager
Dustin Lewellyn, Ernesto Tong, Anand Desai
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
IBD Breakout Stocks Index
Category
Broad Equity
Focus
Strategy
Development Level
Developed Markets
Region
North America
Number of Holdings
42

Fund Statistics

Assets Under Management
$13.92 million
Average Daily Volume
$3,180.10
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Innovator Capital Management, LLC
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
100 shs

Miscellaneous

Beta
1.03
Creation Unit
50,000
Creation Fee
$250.00
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Top 10 BOUT Holdings

BOUT Sector Exposure

BOUT Industry Exposure


This page (NYSEARCA:BOUT) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners